Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.

Mol Genet Genomic Med · 2020 · PMC7434605 · PMID 32441489

Europe PMC DOI

hedged sentence

0.4000

closest p · 8.0× alpha

0.4000

boldest claim

The sentences

showed a trendp = .4not close (p > 0.1)

Furthermore, although not statistically significant, patients in the high apoE group showed a trend of younger onset age (31.1 ± 19.1 vs. 34.9 ± 14.0 years old, p = .4), higher MAP (106.8 ± 15.1 vs. 101.7 ± 15.6 mmHg, p = .4), higher Upro [ln(Upro): 1.0 ± 0.9 vs. 0.8 ± 1.2 g/24 hr, p = .5], and higher TG levels [ln(TG): 1.1 ± 0.5 vs. 0.9 ± 0.6 mmol/L, p = .2] compared with patients in the low apoE group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.